Pathophysiology of obesity
Pathophysiology of Obesity
The Pathophysiology of Obesity refers to the scientific study of the functional changes that accompany or result from obesity, a medical condition characterized by an excess of body fat. Obesity is associated with a number of health risks, including heart disease, type 2 diabetes, hypertension, certain types of cancer, and sleep apnea.
Causes[edit | edit source]
Obesity is primarily caused by a combination of excessive food intake, lack of physical activity, and genetic susceptibility. A few cases are caused primarily by genes, endocrine disorders, medications, or mental disorder. The view that obesity is a disorder of the distribution of stored energy is supported by the fact that the BMI (Body Mass Index) is strongly correlated with various metabolic and disease outcomes.
Health Risks[edit | edit source]
Obesity increases the likelihood of various diseases and conditions, particularly cardiovascular disease, type 2 diabetes, obstructive sleep apnea, certain types of cancer, and osteoarthritis. Obesity is most commonly caused by a combination of excessive food intake, lack of physical activity, and genetic susceptibility, although a few cases are caused primarily by genes, endocrine disorders, medications, or mental disorder.
Treatment[edit | edit source]
Treatment of obesity primarily involves lifestyle changes such as diet and exercise. In some cases, medications or surgery may be recommended.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Pathophysiology of obesity Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD